ELEVANCE HEALTH INC (1ANTM.MI) Fundamental Analysis & Valuation

BIT:1ANTM • US0367521038

315.5 EUR
+11.3 (+3.71%)
Last: Jan 7, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 1ANTM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1ANTM. 1ANTM was compared to 30 industry peers in the Health Care Providers & Services industry. 1ANTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1ANTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. 1ANTM.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ANTM was profitable.
  • In the past year 1ANTM had a positive cash flow from operations.
  • In the past 5 years 1ANTM has always been profitable.
  • Each year in the past 5 years 1ANTM had a positive operating cash flow.
1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCF1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • 1ANTM's Return On Assets of 4.51% is fine compared to the rest of the industry. 1ANTM outperforms 78.13% of its industry peers.
  • 1ANTM has a Return On Equity of 12.59%. This is in the better half of the industry: 1ANTM outperforms 68.75% of its industry peers.
  • 1ANTM's Return On Invested Capital of 5.60% is in line compared to the rest of the industry. 1ANTM outperforms 53.13% of its industry peers.
  • 1ANTM had an Average Return On Invested Capital over the past 3 years of 6.90%. This is in line with the industry average of 6.83%.
Industry RankSector Rank
ROA 4.51%
ROE 12.59%
ROIC 5.6%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1ANTM.MI Yearly ROA, ROE, ROIC1ANTM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of 1ANTM (2.84%) is better than 65.63% of its industry peers.
  • In the last couple of years the Profit Margin of 1ANTM has declined.
  • With a Operating Margin value of 4.35%, 1ANTM perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
  • 1ANTM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.35%
PM (TTM) 2.84%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
1ANTM.MI Yearly Profit, Operating, Gross Margins1ANTM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. 1ANTM.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ANTM is destroying value.
  • 1ANTM has less shares outstanding than it did 1 year ago.
  • 1ANTM has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1ANTM is higher compared to a year ago.
1ANTM.MI Yearly Shares Outstanding1ANTM.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1ANTM.MI Yearly Total Debt VS Total Assets1ANTM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • 1ANTM has a debt to FCF ratio of 8.63. This is a slightly negative value and a sign of low solvency as 1ANTM would need 8.63 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 8.63, 1ANTM perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
  • 1ANTM has a Debt/Equity ratio of 0.71. This is a neutral value indicating 1ANTM is somewhat dependend on debt financing.
  • The Debt to Equity ratio of 1ANTM (0.71) is better than 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 8.63
Altman-Z N/A
ROIC/WACC0.66
WACC8.46%
1ANTM.MI Yearly LT Debt VS Equity VS FCF1ANTM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
1ANTM.MI Yearly Current Assets VS Current Liabilites1ANTM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1ANTM.MI Growth Analysis

3.1 Past

  • 1ANTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.71%.
  • Measured over the past years, 1ANTM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
  • 1ANTM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.96%.
  • Measured over the past years, 1ANTM shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%

3.2 Future

  • 1ANTM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.64% yearly.
  • The Revenue is expected to grow by 4.62% on average over the next years.
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue Next Year13.09%
Revenue Next 2Y8.09%
Revenue Next 3Y6.88%
Revenue Next 5Y4.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1ANTM.MI Yearly Revenue VS Estimates1ANTM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B
1ANTM.MI Yearly EPS VS Estimates1ANTM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

More info and screens

Find the best growth stocksShow best growing peers

4

4. 1ANTM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.95, the valuation of 1ANTM can be described as very reasonable.
  • 75.00% of the companies in the same industry are more expensive than 1ANTM, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.29. 1ANTM is valued rather cheaply when compared to this.
  • 1ANTM is valuated correctly with a Price/Forward Earnings ratio of 13.42.
  • Based on the Price/Forward Earnings ratio, 1ANTM is valued a bit cheaper than 65.63% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, 1ANTM is valued a bit cheaper.
Industry RankSector Rank
PE 11.95
Fwd PE 13.42
1ANTM.MI Price Earnings VS Forward Price Earnings1ANTM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1ANTM.
  • Based on the Price/Free Cash Flow ratio, 1ANTM is valued a bit more expensive than the industry average as 65.63% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 21.89
EV/EBITDA 10.45
1ANTM.MI Per share data1ANTM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.07
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. 1ANTM.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.79%, 1ANTM has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.55, 1ANTM pays a bit more dividend than its industry peers.
  • 1ANTM's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.79%

5.2 History

  • On average, the dividend of 1ANTM grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1ANTM pays out 27.56% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of 1ANTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
1ANTM.MI Yearly Income VS Free CF VS Dividend1ANTM.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
1ANTM.MI Dividend Payout.1ANTM.MI Dividend Payout, showing the Payout Ratio.1ANTM.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1ANTM.MI Fundamentals: All Metrics, Ratios and Statistics

ELEVANCE HEALTH INC

BIT:1ANTM (1/7/2026, 7:00:00 PM)

315.5

+11.3 (+3.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-21
Earnings (Next)01-28
Inst Owners91.68%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap70.12B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts73.57
Price Target335.28 (6.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.79%
Yearly Dividend5.64
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)3
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)5
Avg Revenue beat(8)0.79%
Revenue beat(12)7
Avg Revenue beat(12)1%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)5.44%
PT rev (3m)5.44%
EPS NQ rev (1m)-24.94%
EPS NQ rev (3m)-24.94%
EPS NY rev (1m)0.31%
EPS NY rev (3m)0.31%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 11.95
Fwd PE 13.42
P/S 0.42
P/FCF 21.89
P/OCF 16.74
P/B 1.85
P/tB 19.51
EV/EBITDA 10.45
EPS(TTM)26.41
EY8.37%
EPS(NY)23.51
Fwd EY7.45%
FCF(TTM)14.41
FCFY4.57%
OCF(TTM)18.85
OCFY5.97%
SpS754.6
BVpS170.24
TBVpS16.17
PEG (NY)N/A
PEG (5Y)1.07
Graham Number318.06
Profitability
Industry RankSector Rank
ROA 4.51%
ROE 12.59%
ROCE 7.32%
ROIC 5.6%
ROICexc 6.06%
ROICexgc 10.93%
OM 4.35%
PM (TTM) 2.84%
GM N/A
FCFM 1.91%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 8.63
Debt/EBITDA 3.13
Cap/Depr 74.45%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 48.59%
Profit Quality 67.25%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.46%
ROIC/WACC0.66
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
Revenue Next Year13.09%
Revenue Next 2Y8.09%
Revenue Next 3Y6.88%
Revenue Next 5Y4.62%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-2.04%
EBIT Next 3Y0.56%
EBIT Next 5Y8.31%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%

ELEVANCE HEALTH INC / 1ANTM.MI FAQ

What is the ChartMill fundamental rating of ELEVANCE HEALTH INC (1ANTM.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1ANTM.MI.


What is the valuation status of ELEVANCE HEALTH INC (1ANTM.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (1ANTM.MI). This can be considered as Fairly Valued.


How profitable is ELEVANCE HEALTH INC (1ANTM.MI) stock?

ELEVANCE HEALTH INC (1ANTM.MI) has a profitability rating of 4 / 10.


What is the financial health of ELEVANCE HEALTH INC (1ANTM.MI) stock?

The financial health rating of ELEVANCE HEALTH INC (1ANTM.MI) is 3 / 10.


What is the expected EPS growth for ELEVANCE HEALTH INC (1ANTM.MI) stock?

The Earnings per Share (EPS) of ELEVANCE HEALTH INC (1ANTM.MI) is expected to decline by -8.14% in the next year.